雅虎香港 搜尋

搜尋結果

  1. 2024年5月15日 · At SID Display Week 2024, BOE makes a big splash by debuting a slew of industry-leading display technologies and products empowered by its three display technology brands. Into the exhibition zone, visitors are welcomed by a gigantic 110-inch 16K

  2. 2023年2月9日 · New York's Museum at FIT is celebrating 50 years of hip-hop style with a truly awesome exhibition: Fresh, Fly, and Fabulous: Fifty Years of Hip Hop Style. FIT 紐約博物館正在慶祝嘻哈風格 50 週年,並舉辦真正令人敬畏的展覽: 清新、飛翔、神話般:五十年嘻哈風格。

  3. PT-V是力勁集團深挖客戶需求推出的第五代精密注塑機。 全系標配電熔膠技術、同時對鎖模,機鉸等結構進行了全面優化升級,減少了衝擊力,運行更高效、平穩;整機動力提升15%-25%,成型週期縮短10%-20%;射臺結構新增電預塑接口,可根據客戶需求自由選擇電預塑或液壓馬達預塑;採用高精度線性導軌注射單元,結構更加緊湊;該系列採用了靈活的模塊設計,通過搭配不同注射&射膠組合,滿足客戶的多方位需求。 EL-250電動式PET專機. 力勁經過連續4代PET專機的技術沉澱,成功打造了全新第五代PET電動專機。 該機器充分發揮了電動機控制精度高,穩定性好,效率高等技術優勢,配合射膠螺桿結構、高扭矩熔膠技術的PET專項優化,極大提升了PET注塑成型的效率與產品穩定性,產品合格率高達95%以上。

  4. 2024年3月27日 · 預計到2029年,全球活動管理市場將達到1.76萬億美元,從2023年到2029年將以11.06%的複合年增長率增長。. The global event management market is a dynamic and competitive industry encompassing various services and solutions for planning, organizing, and executing various events, from corporate meetings ...

  5. 2023年1月3日 · LAS VEGAS, Jan. 03, 2023 (GLOBE NEWSWIRE) -- Synaptics ® Incorporated (Nasdaq: SYNA) today announced two quad-display systems on chip (SoCs): the VMM9430 is the industry's first DisplayPort 2.1 (DP 2.1) multi-stream transport (MST) hub, and the DisplayLink DL-7400 is a universal display docking solution with built-in Internet of ...

  6. 2024年4月18日 · INDIANAPOLIS, April 18, 2024 /PRNewswire/ -- Ardagh Glass Packaging-North America (AGP-North America), a business of Ardagh Group, announced today it will showcase its glass packaging beer and beverage portfolio at the 2024 Craft Brewers Conference/BrewExpo America (CBC).

  7. 2022年4月9日 · Covalent menin inhibitor BMF-219 showed strong cytotoxic activity as a single agent at similar concentrations across multiple preclinical patient derived (PDX) models ex vivo, including diffuse large B-cell lymphoma (DLBCL), multiple myeloma (MM), colorectal cancer (CRC), non-small cell lung cancer (NSCLC), and pancreatic cancer.